Clinical Trial Diversity Action Plans Need Timely FDA Feedback, Groups Say

 
• By Sue Sutter
  
Diversity paper cutouts
Sponsors would like FDA feedback on their clinical trial diversity action plans. (Shutterstock)
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

More from United States